SABS EV/EBITDA
-0.70
-0.01-1.45%
Wed, 22 Jan 2025 22:00:40 GMT
Summary:
As of January 23, 2025, SABS EV/EBITDA is -0.70, with a fall of -0.01 (-1.45%) during the most recent trading day. Over the past year, it has dropped by -0.62 (-775.00%). SABS EV/EBITDA is now -318.75% below its all-time high of 0.32.SABS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -1.4% |
| 1 m1 month | +23.9% |
| 3 m3 months | -14.8% |
| 6 m6 months | -55.6% |
| ytdytd | +6.7% |
| 1 y1 year | -775.0% |
| 5 y5 years | - |
SABS EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -0.66 | -6.1% | -0.92 | +23.9% |
| 3 m | 3-month | -0.49 | -42.9% | -0.92 | +23.9% |
| 6 m | 6-month | -0.24 | -191.7% | -0.92 | +23.9% |
| 1 y | 1-year | 0.32 | -318.8% | -1.02 | +31.4% |
| 3 y | 3-year | 0.32 | -318.8% | -15.80 | +95.6% |
| 5 y | 5-year | 0.32 | -318.8% | -111.60 | +99.4% |
| alltime | all time | 0.32 | -318.8% | -111.60 | +99.4% |
SAB Biotherapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.70(-6.7%) |
| 2024 | -0.75(+120.6%) |
| Date | Value |
|---|---|
| 2023 | -0.34(-75.0%) |
| 2022 | -1.36(-93.4%) |
| 2021 | -20.72 |
FAQ
- What is SAB Biotherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for SAB Biotherapeutics?
- What is SABS EV/EBITDA year-to-date change?
- What is SAB Biotherapeutics EV/EBITDA year-on-year change?
What is SAB Biotherapeutics EV/EBITDA?
The current EV/EBITDA of SABS is -0.70
What is the all time high EV/EBITDA for SAB Biotherapeutics?
SAB Biotherapeutics all-time high EV/EBITDA is 0.32
What is SABS EV/EBITDA year-to-date change?
SAB Biotherapeutics EV/EBITDA has changed by +0.05 (+6.67%) since the beginning of the year
What is SAB Biotherapeutics EV/EBITDA year-on-year change?
Over the past year, SABS EV/EBITDA has changed by -0.62 (-775.00%)